Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: Malaysia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20152
20161
20182
20202
20212
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Amgen1
Astellas Pharma Global Development, Inc.1
Bioven Europe1
Bioven Sdn. Bhd.1
Checkpoint Therapeutics, Inc.1
Formycon AG1
Hanmi Pharmaceutical Company Limited1
Merck Sharp & Dohme LLC1
Xencor, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms6
Neoplasm Metastasis2
Anemia1
Neoplasms1
Pleural Effusion1
Pleural Effusion, Malignant1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.